SCHEMBL8749480

SCHEMBL8749480

CC(C)(C)OC(=O)c1cccc(CN)c1CN

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.38
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
EGFR P00533 1/20 0.36
KCNA5 P22460 1/20 0.35
NR1H2 P55055 2/20 0.34
HMGB1 P09429 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
LOXL2 Q9Y4K0 2/20 0.33
AR P10275 1/20 0.33
RXRA P19793 1/20 0.33
NR1H3 Q13133 1/20 0.33
GRM6 O15303 1/20 0.33
NQO2 P16083 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4838670 0.85 ALDH1A1 (0.41) SLC7A5ADRA1AADRA1BEGFRKCNA5
SCHEMBL29531759 0.84 SLC7A5 (0.41) SLC7A5ADRA1AADRA1BNR1H2HMGB1
SCHEMBL27503212 0.84 TSHR (0.39) SLC7A5ADRA1AADRA1BEGFRNR1H2
SCHEMBL4520357 0.84 SLC7A5 (0.41) SLC7A5ADRA1AADRA1BNR1H2HMGB1
Hydrochloric Acid SCHEMBL4838664 0.84 ALDH1A1 (0.41) SLC7A5ADRA1AADRA1BEGFRKCNA5
SCHEMBL27637322 0.82 CTSD (0.43) SLC7A5CA12CA1CA2CA9
SCHEMBL19126688 0.81 SLC7A5 (0.36) SLC7A5ADRA1AADRA1BEGFRNR1H2
SCHEMBL5841080 0.79 SLC7A5 (0.42) SLC7A5NR1H2HMGB1RXRANR1H3
SCHEMBL7451046 0.76 ALDH1A1 (0.33) SLC7A5ADRA1AADRA1BNR1H2RXRA
SCHEMBL5697877 0.76 ALDH1A1 (0.46) ADRA1AADRA1BHMGB1GRM6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763016-A1 COMPOSITIONS AND METHODS FOR TREATING MAST-CELL MEDIATED CONDITIONS ARRIS PHARMACEUTICAL CORPORATION (US) 1997-03-19 EP disclosed
WO-1995032945-A1 COMPOSITIONS AND METHODS FOR TREATING MAST-CELL MEDIATED CONDITIONS ARRIS PHARMACEUTICAL CORPORATION (US) 1995-12-07 WO disclosed